Denali Therapeutics Inc.
DNLINext catalyst
DNL593
Frontotemporal Dementia
Get an email about DNLI's next catalysts
Track Denali Therapeutics (DNLI) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
Plus 1 more upcoming event in our data (Phase 2 readout).See the timeline
2 upcoming, 1 past
Market Overview
Stock performance and key metrics
tividenofusp alfa
Mucopolysaccharidosis II
idursulfase
Mucopolysaccharidosis II
DNL343
Amyotrophic Lateral Sclerosis
Prophylactic immunomodulatory therapy
Mucopolysaccharidosis Type IIIA
DNL593
Frontotemporal Dementia
DNL126
Mucopolysaccharidosis Type IIIA
BIIB122
Parkinson Disease
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
tividenofusp alfa | Phase 3 | Mucopolysaccharidosis II | - | - |
idursulfase | Phase 3 | Mucopolysaccharidosis II | - | - |
DNL343 | Phase 3 | Amyotrophic Lateral Sclerosis | - | - |
Prophylactic immunomodulatory therapy | Phase 2 | Mucopolysaccharidosis Type IIIA | - | - |
DNL593 | Phase 2 | Frontotemporal Dementia | - | - |
DNL126 | Phase 2 | Mucopolysaccharidosis Type IIIA | - | - |
BIIB122 | Phase 2 | Parkinson Disease | - | - |
Mucopolysaccharidosis II
2 drugs in this indication
Parkinson Disease
2 drugs in this indication
Frontotemporal Dementia
1 drug in this indication
Mucopolysaccharidosis Type IIIA
1 drug in this indication
Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)
Frequently asked questions
What is in Denali Therapeutics Inc.'s drug pipeline?β
CatalystAlert tracks 7 drug candidates in Denali Therapeutics Inc.'s (DNLI) pipeline across Phase 3, Phase 2. Its lead program is DNL343 (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Denali Therapeutics Inc.'s next FDA catalyst?β
Denali Therapeutics Inc.'s (DNLI) next tracked catalyst is a Phase 2 readout expected December 2026. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.
How do I track DNLI biotech catalysts?β
Add DNLI to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Denali Therapeutics Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page β sourced from ClinicalTrials.gov, FDA and SEC filings.
